GlassScriptPhysician profile
Becca Dawn Barth
NPI 1932879665
$750.91
in general payments reported to CMS, 2019-2025
13 companies · $505 in 2025
The $505 reported for 2025 was more than what 92% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $20.69 · 2023: $89.64 · 2024: $136 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $730.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $730.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alkermes, INC. | $118.83 | 2025 | Aristada, Lybalvi |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $100.37 | 2025 | Caplyta |
| Vanda Pharmaceuticals INC. | $89.09 | 2025 | Fanapt |
| Merck Sharp & Dohme LLC | $81.35 | 2022-2024 | Vaxneuvance, Vaxelis, Proquad |
| Glaxosmithkline, LLC. | $78.40 | 2023-2025 | Bexsero, Shingrix, Arexvy |
| Abbvie INC. | $55.13 | 2023-2024 | |
| Supernus Pharmaceuticals, INC. | $44.25 | 2024-2025 | Qelbree |
| Exact Sciences Corporation | $41.93 | 2024-2025 | Cologuard Collection Kit |
| Collegium Pharmaceutical, INC. | $37.02 | 2025 | Jornay Pm |
| Janssen Pharmaceuticals, INC | $35.99 | 2025 | Spravato |
| Sanofi Pasteur INC. | $35.49 | 2025 | |
| Otsuka America Pharmaceutical, INC. | $16.60 | 2023 | Nuedexta |
| Pfizer INC. | $16.46 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Becca Barth listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.